DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Methotrexate (Methotrexate) - Infection - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Infection (101)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Methotrexate where reactions include infection. The selected reports were submitted to the FDA during the sample period of about a year.

 Reports 1 - 30 of 101   Next >>

Possible Methotrexate side effects in

Reported by a physician from United States on 2012-08-20

Patient:

Reactions: Abdominal Pain, Thrombosis, Hyperkalaemia, Hypoglycaemia, Coagulopathy, Hypokalaemia, Blood Bilirubin Abnormal, Hiccups, Pleural Effusion, Hypoxia, Hypocalcaemia, Alanine Aminotransferase Abnormal, Cough, Pneumonitis, Decreased Appetite, Pain in Extremity, Hypotension, Hyperglycaemia, Gamma-Glutamyltransferase Abnormal, Hyponatraemia, External Ear Pain, Hypercalcaemia, Haematotoxicity, Hypophosphataemia, Diarrhoea, Dehydration, Hypoalbuminaemia, Lower Gastrointestinal Haemorrhage, Hypertension, Hypofibrinogenaemia, Aspartate Aminotransferase Abnormal, Infection

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Bortezomib
    Dosage: 1.3 mg/sq.m/dose on days 1, 4, 8 and 11 combined with vxld
    Indication: Acute Lymphocytic Leukaemia

Vincristine
    Dosage: 1.5 mg/m2/dose, max. 2 mg, by push on days 1, 8, 15 and 22
    Indication: Acute Lymphocytic Leukaemia

Doxorubicin Hydrochloride
    Dosage: given over 15-30 minutes on day 1
    Indication: Acute Lymphocytic Leukaemia

Dexamethasone
    Dosage: 10 mg/m2/day divided in to 2 doses for 14 consecutive days
    Administration route: Oral
    Indication: Acute Lymphocytic Leukaemia

Cytarabine
    Dosage: on day 1 for all patients and on days 8, 15, 22 for cns invlovment
    Indication: Acute Lymphocytic Leukaemia

Asparaginase
    Dosage: 2500 units/m2/dose as 4 weekly doses
    Indication: Acute Lymphocytic Leukaemia

Hydrocortisone
    Dosage: on days 8, 15 and 22
    Indication: Acute Lymphocytic Leukaemia

Methotrexate
    Dosage: 1 dose on day 15 for no cns involvement and on days 8, 15, 22 for cns involvement
    Indication: Acute Lymphocytic Leukaemia

Other drugs received by patient: Levofloxacin; Voriconazole; Posaconazole; Vancomycin



Possible Methotrexate side effects in

Reported by a physician from United States on 2012-08-14

Patient:

Reactions: Thrombosis, Abdominal Pain, Hyperkalaemia, Hypoglycaemia, Coagulopathy, Hypoxia, Hypocalcaemia, Hiccups, Alanine Aminotransferase Abnormal, Cough, Pneumonitis, Pain in Extremity, Hyperglycaemia, Hypotension, External Ear Pain, Haematotoxicity, Dehydration, Lower Gastrointestinal Haemorrhage, Hypofibrinogenaemia, Aspartate Aminotransferase Abnormal, Hypokalaemia, Neuropathy Peripheral, Blood Bilirubin Abnormal, Pleural Effusion, Decreased Appetite, Hyponatraemia, Gamma-Glutamyltransferase Abnormal, Hypercalcaemia, Hypophosphataemia, Diarrhoea, Hypoalbuminaemia, Hypertension, Infection

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Vincristine
    Dosage: 1.5 mg/m2/dose, max. 2 mg, by push on days 1, 8, 15 and 22
    Indication: Acute Lymphocytic Leukaemia

Methotrexate
    Dosage: 1 dose on day 15 for no cns involvement and on days 8, 15, 22 for cns involvement
    Indication: Acute Lymphocytic Leukaemia

Bortezomib
    Dosage: 1.3 mg/sq.m/dose on days 1, 4, 8 and 11 combined with vxld
    Indication: Acute Lymphocytic Leukaemia

Doxorubicin Hydrochloride
    Dosage: given over 15-30 minutes on day 1
    Indication: Acute Lymphocytic Leukaemia

Asparaginase
    Dosage: 2500 units/m2/dose as 4 weekly doses
    Indication: Acute Lymphocytic Leukaemia

Cytarabine
    Dosage: on day 1 for all patients and on days 8, 15, 22 for cns invlovment
    Indication: Acute Lymphocytic Leukaemia

Hydrocortisone
    Dosage: on days 8, 15 and 22
    Indication: Acute Lymphocytic Leukaemia

Dexamethasone
    Dosage: 10 mg/m2/day divided in to 2 doses for 14 consecutive days
    Administration route: Oral
    Indication: Acute Lymphocytic Leukaemia

Other drugs received by patient: Levofloxacin; Vancomycin; Posaconazole; Voriconazole



Possible Methotrexate side effects in 66 month old female

Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-08-09

Patient: 66 month old female

Reactions: Urinary Tract Infection, Infection

Drug(s) suspected as cause:
Methotrexate



Possible Methotrexate side effects in male

Reported by a consumer/non-health professional from United States on 2012-08-02

Patient: male, weighing 119.8 kg (263.5 pounds)

Reactions: Diabetes Mellitus, Abasia, Perineal Cyst, Decreased Immune Responsiveness, Intervertebral Disc Degeneration, Abnormal Loss of Weight, Oxygen Saturation Decreased, Intervertebral Disc Protrusion, Fistula, Gout, Convulsion, Cholelithiasis, Diarrhoea, Sepsis, Heart Rate Increased, Arthritis, Infection

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Colchicine
    Administration route: Oral
    Indication: Gout
    Start date: 2012-05-01

Novolog
    Dosage: 40 units/solution before meals
    Indication: Diabetes Mellitus
    Start date: 2011-01-01
    End date: 2011-01-01

Remicade
    Indication: Crohn's Disease
    Start date: 2004-09-09
    End date: 2010-01-01

Methotrexate
    Administration route: Oral
    Indication: Intervertebral Disc Protrusion
    Start date: 2011-01-01
    End date: 2011-01-01

Levemir
    Dosage: 52 units/ at night/subcutaneous
    Indication: Diabetes Mellitus

Remicade
    Start date: 2010-01-01

Other drugs received by patient: Flomax; Dilaudid; Ambien; Valium; Hydrochlorothiazide; Cymbalta; Lyrica; Lisinopril; Simvastatin; Nexium; Humalog; Onglyza



Possible Methotrexate side effects in female

Reported by a individual with unspecified qualification from United States on 2012-07-27

Patient: female, weighing 56.3 kg (123.9 pounds)

Reactions: Blood Bilirubin Increased, Tachycardia, Disseminated Intravascular Coagulation, Pyrexia, Acidosis, Abdominal Tenderness, Labile Blood Pressure, Hypoxia, Unevaluable Event, Blood Creatinine Increased, Epistaxis, Mouth Haemorrhage, Hypotension, Blood Lactate Dehydrogenase Increased, Encephalopathy, Hyperammonaemia, Sinusitis Fungal, Pulseless Electrical Activity, Hepatic Function Abnormal, Skin Exfoliation, Haemorrhage, Mental Status Changes, Serum Ferritin Increased, Oral Herpes, Weight Increased, Dialysis, Tachypnoea, Dizziness, Drug Clearance Decreased, Fluid Overload, Vomiting, Febrile Neutropenia, Hepatic Enzyme Increased, Renal Impairment, Lower Respiratory Tract Infection Fungal, Diarrhoea, Respiratory Failure, Oliguria, Bradycardia, Hypertension, Cardiac Arrest, Klebsiella Test Positive, Nasal Ulcer, Infection

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Methotrexate
    Dosage: 15 mg it, : 290mg x2 iv

Vincristine Sulfate
    Dosage: 4 mg iv

Other drugs received by patient: Fluconazole; Amphotericin B; Piperacillin and Tazobactam; Fligrastim; Vancomycin; Valacyclovir Hydrochloride; Dexamethasone; Etoposide



Possible Methotrexate side effects in

Reported by a physician from United Kingdom on 2012-07-17

Patient:

Reactions: Abdominal Pain, Tachycardia, Skin Toxicity, Pyrexia, Fatigue, Neuropathy Peripheral, Hepatotoxicity, Adverse Event, Dizziness, Oedema, Hallucination, Vomiting, Nausea, Gastrointestinal Toxicity, Neutropenic Sepsis, Nephropathy Toxic, Hypotension, Condition Aggravated, Adult T-Cell Lymphoma / Leukaemia, Mucosal Inflammation, Lung Disorder, Infection, Infusion Related Reaction

Adverse event resulted in: death

Drug(s) suspected as cause:
Hydrocortisone
    Indication: Adult T-Cell Lymphoma / Leukaemia

Doxorubicin HCL
    Dosage: on day 1 of 21 day, (cycle 1-5)

Cytarabine
    Indication: Adult T-Cell Lymphoma / Leukaemia

Cyclophosphamide
    Dosage: on day 1 of 21 day cycle, (cycle 1-5)
    Indication: Adult T-Cell Lymphoma / Leukaemia

Zenapax
    Dosage: on days 7 and 14 on cycle 1 of 21 day cycle
    Indication: Adult T-Cell Lymphoma / Leukaemia

Vincristine
    Dosage: (maximum 2 mg) on day 1 of 21 day cycle, (cycle 1-5)
    Indication: Adult T-Cell Lymphoma / Leukaemia

Prednisolone
    Dosage: on days 1-5 of 21 day cycle, (cycle 1-5)
    Administration route: Oral
    Indication: Adult T-Cell Lymphoma / Leukaemia

Methotrexate
    Indication: Adult T-Cell Lymphoma / Leukaemia

Radiotherapy
    Indication: Adult T-Cell Lymphoma / Leukaemia

Doxorubicin HCL
    Dosage: on day 1 of 21 day, (cycle 1-5)
    Indication: Adult T-Cell Lymphoma / Leukaemia

Other drugs received by patient: Acyclovir; Thiabendazole; Cotrim; Itraconazole



Possible Methotrexate side effects in 50 year old female

Reported by a health professional (non-physician/pharmacist) from NEW Zealand on 2012-07-16

Patient: 50 year old female

Reactions: Diarrhoea, Pneumonitis, Infection

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Bevacizumab
    Indication: Product Used FOR Unknown Indication

Etanercept
    Indication: Psoriatic Arthropathy
    Start date: 2011-05-04
    End date: 2011-06-07

Pegfilgrastim
    Indication: Product Used FOR Unknown Indication

Methotrexate
    Administration route: Oral
    Indication: Psoriatic Arthropathy
    Start date: 2010-10-07
    End date: 2011-06-07

Other drugs received by patient: Folic Acid; Prednisolone; Acetaminophen; Cilazapril; Carbamazepine; Metformin Hydrochloride; Diclofenac Sodium; Gliclazide



Possible Methotrexate side effects in female

Reported by a physician from Japan on 2012-07-16

Patient: female

Reactions: Skin Ulcer, Infection

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Actemra
    Start date: 2010-01-29
    End date: 2010-02-26

Methylprednisolone
    Administration route: Oral
    Indication: Rheumatoid Arthritis

Actemra
    Indication: Rheumatoid Arthritis
    Start date: 2009-06-26
    End date: 2009-11-27

Actemra
    Start date: 2010-07-09
    End date: 2010-12-24

Actemra
    Start date: 2010-05-28
    End date: 2010-05-28

Methotrexate
    Administration route: Oral
    Indication: Rheumatoid Arthritis

Methylprednisolone
    Administration route: Oral

Other drugs received by patient: Famotidine D; Isoniazid; Brotizolam; Mobic; Alfacalcidol; Mucosta; Magmitt; Actonel



Possible Methotrexate side effects in

Reported by a individual with unspecified qualification from Croatia (Local Name: Hrvatska) on 2012-07-13

Patient:

Reactions: Mucosal Inflammation, Multi-Organ Failure, Tumour Lysis Syndrome, Febrile Neutropenia, Infection

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Cyclophosphamide
    Indication: Burkitt's Lymphoma

Cytarabine
    Indication: Burkitt's Lymphoma

Prednisone
    Indication: Burkitt's Lymphoma

Methotrexate
    Indication: Burkitt's Lymphoma

Methylprednisolone
    Indication: Prophylaxis

Vincristine
    Indication: Burkitt's Lymphoma

Mabthera
    Indication: Burkitt's Lymphoma

Ifosfamide
    Indication: Burkitt's Lymphoma

Doxorubicin Hydrochloride
    Indication: Burkitt's Lymphoma

Etoposide
    Indication: Burkitt's Lymphoma

Dexamethasone
    Indication: Burkitt's Lymphoma



Possible Methotrexate side effects in

Reported by a physician from United Kingdom on 2012-07-10

Patient:

Reactions: Abdominal Pain, Skin Toxicity, Tachycardia, Pyrexia, Fatigue, Neuropathy Peripheral, Hepatotoxicity, Adverse Event, Oedema, Dizziness, Hallucination, Vomiting, Gastrointestinal Toxicity, Nausea, Neutropenic Sepsis, Nephropathy Toxic, Hypotension, Adult T-Cell Lymphoma / Leukaemia, Condition Aggravated, Mucosal Inflammation, Lung Disorder, Infection, Infusion Related Reaction

Adverse event resulted in: death

Drug(s) suspected as cause:
Cyclophosphamide
    Dosage: on day 1 of 21 day cycle, (cycle 1-5)
    Indication: Adult T-Cell Lymphoma / Leukaemia

Prednisolone
    Dosage: on days 1-5 of 21 day cycle, (cycle 1-5)
    Administration route: Oral
    Indication: Adult T-Cell Lymphoma / Leukaemia

Cytarabine
    Indication: Adult T-Cell Lymphoma / Leukaemia

Doxorubicin HCL
    Dosage: on day 1 of 21 day, (cycle 1-5)
    Indication: Adult T-Cell Lymphoma / Leukaemia

Vincristine
    Dosage: (maximum 2 mg) on day 1 of 21 day cycle, (cycle 1-5)
    Indication: Adult T-Cell Lymphoma / Leukaemia

Methotrexate
    Indication: Adult T-Cell Lymphoma / Leukaemia

Zenapax
    Dosage: on days 7 and 14 on cycle 1 of 21 day cycle
    Indication: Adult T-Cell Lymphoma / Leukaemia

Hydrocortisone
    Indication: Adult T-Cell Lymphoma / Leukaemia

Radiotherapy
    Indication: Adult T-Cell Lymphoma / Leukaemia

Other drugs received by patient: Cotrim; Itraconazole; Thiabendazole; Acyclovir



Possible Methotrexate side effects in female

Reported by a consumer/non-health professional from United States on 2012-07-05

Patient: female, weighing 66.7 kg (146.7 pounds)

Reactions: Nasopharyngitis, Diabetes Mellitus, Body Temperature Increased, Body Height Decreased, Arthropathy, Hair Growth Abnormal, Musculoskeletal Stiffness, Adverse Event, Hepatic Enzyme Abnormal, Back Pain, Cardiac Murmur, Breast Disorder, Menopause, Seasonal Allergy, Blood Testosterone Increased, Alopecia, Sleep Apnoea Syndrome, Blood Pressure Fluctuation, Infection

Drug(s) suspected as cause:
Methotrexate
    Indication: Product Used FOR Unknown Indication
    End date: 2011-11-01

Remicade
    Start date: 2008-01-01

Remicade
    Start date: 2009-01-01

Remicade
    Indication: Psoriatic Arthropathy
    Start date: 2012-02-08

Lipitor
    Indication: Blood Cholesterol Increased

Benicar
    Indication: Hypertension
    Start date: 2010-01-01
    End date: 2012-02-01

Other drugs received by patient: Naproxen; Advair Diskus 100 / 50; Vitamins and Minerals; Metformin HCL; Nasonex; Zetia; Spironolactone; Spironolactone; Singulair



Possible Methotrexate side effects in

Reported by a physician from United States on 2012-07-05

Patient:

Reactions: Fatigue, Central Nervous System Haemorrhage, Erythema Multiforme, Dyspnoea, Stomatitis, Vomiting, Gastrointestinal Toxicity, Nausea, Condition Aggravated, Rash, Haematotoxicity, Pulmonary Haemorrhage, Tumour Lysis Syndrome, Diarrhoea, Respiratory Failure, Neurological Symptom, Infection

Adverse event resulted in: death

Drug(s) suspected as cause:
Prednisone
    Dosage: for 7 days in cycle 1
    Indication: Burkitt's Lymphoma

Etoposide
    Dosage: on days 4 and 5 of cycle 2,4 and 6
    Indication: Burkitt's Lymphoma

Dexamethasone Sodium Phosphate
    Dosage: on days 1-5 of cycle 2,4 and 6

Dexamethasone Sodium Phosphate
    Dosage: on days 1-5 of cycle 2,4 and 6

Methotrexate
    Dosage: on day 1 of cycle 3,5 and 7
    Indication: Burkitt's Lymphoma

Methotrexate
    Dosage: on day 1 of cycle 2,4 and 6
    Indication: Burkitt's Leukaemia

Vincristine
    Dosage: on day 1 of cycle 3,5 and 7
    Indication: Burkitt's Lymphoma

Dexamethasone Sodium Phosphate
    Dosage: on days 1-5 of cycle 3,5 and 7
    Indication: Burkitt's Leukaemia

Rituximab
    Dosage: on day 8 from cycle 3 to 7

Rituximab
    Dosage: on day 8 from cycle 3 to 7

Prednisone
    Dosage: for 7 days in cycle 1
    Indication: Burkitt's Leukaemia

Rituximab
    Dosage: day 8 on cycle 2; doage increased to 375 mg/m2 on day 10 and 12
    Indication: Burkitt's Leukaemia

Cyclophosphamide
    Dosage: for 5 days in cycle 1
    Indication: Burkitt's Lymphoma

Vincristine
    Dosage: on day 1 of cycle 2,4 and 6

Cytarabine
    Dosage: on days 4 and 5 of cycle 2,4 and 6
    Indication: Burkitt's Leukaemia

Dexamethasone Sodium Phosphate
    Dosage: on days 1-5 of cycle 3,5 and 7
    Indication: Burkitt's Lymphoma

Cyclophosphamide
    Dosage: days 1-5 during cycle 3,5 and 7

Cytarabine
    Dosage: on days 4 and 5 of cycle 2,4 and 6
    Indication: Burkitt's Lymphoma

Etoposide
    Dosage: on days 4 and 5 of cycle 2,4 and 6
    Indication: Burkitt's Leukaemia

Vincristine
    Dosage: on day 1 of cycle 3,5 and 7

Rituximab
    Dosage: day 8 on cycle 2; doage increased to 375 mg/m2 on day 10 and 12
    Indication: Burkitt's Lymphoma

Doxorubicin HCL
    Dosage: on days 4 and 5 of cycle 3,5 and 7
    Indication: Burkitt's Lymphoma

Ifosfamide
    Dosage: on days 1-5 in cycle 2,4 and 6
    Indication: Burkitt's Lymphoma

Methotrexate
    Dosage: on day 1 of cycle 3,5 and 7

Doxorubicin HCL
    Dosage: on days 4 and 5 of cycle 3,5 and 7
    Indication: Burkitt's Leukaemia

Cyclophosphamide
    Dosage: for 5 days in cycle 1
    Indication: Burkitt's Leukaemia

Cyclophosphamide
    Dosage: days 1-5 during cycle 3,5 and 7

Ifosfamide
    Dosage: on days 1-5 in cycle 2,4 and 6
    Indication: Burkitt's Leukaemia

Methotrexate
    Dosage: on day 1 of cycle 2,4 and 6

Vincristine
    Dosage: on day 1 of cycle 2,4 and 6
    Indication: Burkitt's Leukaemia

Other drugs received by patient: Filgrastim; Unknown Medication; Leucovorin Calcium



Possible Methotrexate side effects in female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-02

Patient: female

Reactions: Toxicity To Various Agents, Infection

Drug(s) suspected as cause:
Tamoxifen Citrate
    Dosage: df daily
    Indication: Breast Cancer

Methotrexate
    Dosage: 40 mg/m2, intravenous
    Indication: Breast Cancer

Cyclophosphamide
    Dosage: 100 mg/m2, oral
    Administration route: Oral
    Indication: Breast Cancer

Fluorouracil
    Dosage: 600 mg/m2, intravenous
    Indication: Breast Cancer



Possible Methotrexate side effects in

Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-02

Patient:

Reactions: Extranodal NK / T-Cell Lymphoma, Nasal Type, Bone Marrow Failure, Neutropenia, Infection

Drug(s) suspected as cause:
Elspar
    Indication: T-Cell Lymphoma Stage IV

Methotrexate
    Indication: T-Cell Lymphoma Stage IV

Ifosfamide
    Indication: T-Cell Lymphoma Stage IV

Dexamethasone
    Indication: T-Cell Lymphoma Stage IV

Etoposide
    Indication: T-Cell Lymphoma Stage IV



Possible Methotrexate side effects in 50 year old female

Reported by a health professional (non-physician/pharmacist) from NEW Zealand on 2012-06-28

Patient: 50 year old female

Reactions: Diarrhoea, Pneumonitis, Infection

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Methotrexate
    Administration route: Oral
    Indication: Psoriatic Arthropathy
    Start date: 2010-10-07
    End date: 2011-06-07

Etanercept
    Indication: Psoriatic Arthropathy
    Start date: 2011-05-04
    End date: 2011-06-07

Bevacizumab
    Indication: Product Used FOR Unknown Indication

Pegfilgrastim
    Indication: Product Used FOR Unknown Indication

Other drugs received by patient: Carbamazepine; Metformin HCL; Gliclazide; Cilazapril / Hydrochlorothiazide; Folic Acid; Prednisolone; Acetaminophen; Diclofenac Sodium



Possible Methotrexate side effects in

Reported by a physician from United States on 2012-06-28

Patient:

Reactions: Fatigue, Central Nervous System Haemorrhage, Erythema Multiforme, Vomiting, Stomatitis, Dyspnoea, Gastrointestinal Toxicity, Nausea, Condition Aggravated, Rash, Haematotoxicity, Pulmonary Haemorrhage, Tumour Lysis Syndrome, Respiratory Failure, Diarrhoea, Neurological Symptom, Infection

Adverse event resulted in: death

Drug(s) suspected as cause:
Etoposide
    Dosage: on days 4 and 5 of cycle 2,4 and 6
    Indication: Burkitt's Leukaemia

Vincristine
    Dosage: on day 1 of cycle 2,4 and 6

Vincristine
    Dosage: on day 1 of cycle 2,4 and 6
    Indication: Burkitt's Leukaemia

Cytarabine
    Dosage: on days 4 and 5 of cycle 2,4 and 6
    Indication: Burkitt's Lymphoma

Rituximab
    Dosage: on day 8 from cycle 3 to 7

Cyclophosphamide
    Dosage: days 1-5 during cycle 3,5 and 7

Prednisone TAB
    Dosage: for 7 days in cycle 1
    Indication: Burkitt's Leukaemia

Vincristine
    Dosage: on day 1 of cycle 3,5 and 7

Dexamethasone
    Dosage: on days 1-5 of cycle 2,4 and 6

Rituximab
    Dosage: day 8 on cycle 2; doage increased to 375 mg/m2 on day 10 and 12
    Indication: Burkitt's Leukaemia

Cyclophosphamide
    Dosage: days 1-5 during cycle 3,5 and 7

Vincristine
    Dosage: on day 1 of cycle 3,5 and 7
    Indication: Burkitt's Lymphoma

Dexamethasone
    Dosage: on days 1-5 of cycle 2,4 and 6

Doxorubicin HCL
    Dosage: on days 4 and 5 of cycle 3,5 and 7
    Indication: Burkitt's Lymphoma

Cyclophosphamide
    Dosage: for 5 days in cycle 1
    Indication: Burkitt's Leukaemia

Ifosfamide
    Dosage: on days 1-5 in cycle 2,4 and 6
    Indication: Burkitt's Lymphoma

Ifosfamide
    Dosage: on days 1-5 in cycle 2,4 and 6
    Indication: Burkitt's Leukaemia

Methotrexate
    Dosage: on day 1 of cycle 3,5 and 7
    Indication: Burkitt's Lymphoma

Doxorubicin HCL
    Dosage: on days 4 and 5 of cycle 3,5 and 7
    Indication: Burkitt's Leukaemia

Methotrexate
    Dosage: on day 1 of cycle 2,4 and 6

Methotrexate
    Dosage: on day 1 of cycle 3,5 and 7

Cyclophosphamide
    Dosage: for 5 days in cycle 1
    Indication: Burkitt's Lymphoma

Prednisone TAB
    Dosage: for 7 days in cycle 1
    Indication: Burkitt's Lymphoma

Cytarabine
    Dosage: on days 4 and 5 of cycle 2,4 and 6
    Indication: Burkitt's Leukaemia

Dexamethasone
    Dosage: on days 1-5 of cycle 3,5 and 7
    Indication: Burkitt's Lymphoma

Rituximab
    Dosage: day 8 on cycle 2; doage increased to 375 mg/m2 on day 10 and 12
    Indication: Burkitt's Lymphoma

Rituximab
    Dosage: on day 8 from cycle 3 to 7

Methotrexate
    Dosage: on day 1 of cycle 2,4 and 6
    Indication: Burkitt's Leukaemia

Etoposide
    Dosage: on days 4 and 5 of cycle 2,4 and 6
    Indication: Burkitt's Lymphoma

Dexamethasone
    Dosage: on days 1-5 of cycle 3,5 and 7
    Indication: Burkitt's Leukaemia

Other drugs received by patient: Unknown Medication; Leucovorin Calcium; Filgrastim



Possible Methotrexate side effects in male

Reported by a physician from Germany on 2012-06-26

Patient: male, weighing 57.0 kg (125.4 pounds)

Reactions: Pseudarthrosis, Soft Tissue Disorder, Fistula, Wound Dehiscence, Impaired Healing, Infection

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Actemra
    Indication: Rheumatoid Arthritis
    Start date: 2010-11-17
    End date: 2011-08-16

Methotrexate
    Indication: Rheumatoid Arthritis
    Start date: 2011-09-01

Other drugs received by patient: Syntestan



Possible Methotrexate side effects in

Reported by a physician from United States on 2012-06-26

Patient:

Reactions: Death, Neoplasm Malignant, Burkitt's Lymphoma Recurrent, Myelodysplastic Syndrome, Burkitt's Leukaemia, Infection

Adverse event resulted in: death

Drug(s) suspected as cause:
Cyclophosphamide
    Indication: Acute Lymphocytic Leukaemia

Methotrexate
    Indication: Acute Lymphocytic Leukaemia

Cyclophosphamide
    Indication: Burkitt's Lymphoma

Methotrexate
    Indication: Burkitt's Lymphoma

Cytarabine
    Indication: Acute Lymphocytic Leukaemia

Monoclonal Antibodies
    Dosage: standard dose
    Indication: Acute Lymphocytic Leukaemia

Monoclonal Antibodies
    Dosage: standard dose
    Indication: Burkitt's Lymphoma

Rituximab
    Dosage: days 1, 11 of hyper-cvad and days 1, 8 of mtx-cytarabine courses
    Indication: Burkitt's Lymphoma

Doxorubicin HCL
    Indication: Acute Lymphocytic Leukaemia

Doxorubicin HCL
    Indication: Burkitt's Lymphoma

Dexamethasone
    Indication: Burkitt's Lymphoma

Cytarabine
    Indication: Burkitt's Lymphoma

Vincristine
    Indication: Acute Lymphocytic Leukaemia

Vincristine
    Indication: Burkitt's Lymphoma

Rituximab
    Dosage: days 1, 11 of hyper-cvad and days 1, 8 of mtx-cytarabine courses
    Indication: Acute Lymphocytic Leukaemia

Dexamethasone
    Indication: Acute Lymphocytic Leukaemia

Other drugs received by patient: Unknown Medication



Possible Methotrexate side effects in

Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-25

Patient:

Reactions: Fatigue, Central Nervous System Haemorrhage, Erythema Multiforme, Stomatitis, Vomiting, Dyspnoea, Nausea, Gastrointestinal Toxicity, Condition Aggravated, Rash, Haematotoxicity, Pulmonary Haemorrhage, Tumour Lysis Syndrome, Diarrhoea, Respiratory Failure, Neurological Symptom, Infection

Adverse event resulted in: death

Drug(s) suspected as cause:
Cyclophosphamide
    Dosage: for 5 days in cycle 1
    Indication: Burkitt's Lymphoma

Methotrexate
    Dosage: on day 1 of cycle 2,4 and 6
    Indication: Burkitt's Leukaemia

Methotrexate
    Dosage: on day 1 of cycle 3,5 and 7

Vincristine
    Dosage: on day 1 of cycle 2,4 and 6
    Indication: Burkitt's Leukaemia

Cytarabine
    Dosage: on days 4 and 5 of cycle 2,4 and 6
    Indication: Burkitt's Leukaemia

Ifosfamide
    Dosage: on days 1-5 in cycle 2,4 and 6
    Indication: Burkitt's Lymphoma

Etoposide
    Dosage: on days 4 and 5 of cycle 2,4 and 6
    Indication: Burkitt's Lymphoma

Etoposide
    Dosage: on days 4 and 5 of cycle 2,4 and 6
    Indication: Burkitt's Leukaemia

Doxorubicin HCL
    Dosage: on days 4 and 5 of cycle 3,5 and 7
    Indication: Burkitt's Lymphoma

Dexamethasone
    Dosage: on days 1-5 of cycle 3,5 and 7
    Indication: Burkitt's Lymphoma

Dexamethasone
    Dosage: on days 1-5 of cycle 2,4 and 6

Rituximab
    Dosage: on day 8 from cycle 3 to 7

Rituximab
    Dosage: on day 8 from cycle 3 to 7

Doxorubicin HCL
    Dosage: on days 4 and 5 of cycle 3,5 and 7
    Indication: Burkitt's Leukaemia

Cyclophosphamide
    Dosage: days 1-5 during cycle 3,5 and 7

Vincristine
    Dosage: on day 1 of cycle 2,4 and 6

Cyclophosphamide
    Dosage: days 1-5 during cycle 3,5 and 7

Vincristine
    Dosage: on day 1 of cycle 3,5 and 7

Cytarabine
    Dosage: on days 4 and 5 of cycle 2,4 and 6
    Indication: Burkitt's Lymphoma

Rituximab
    Dosage: day 8 on cycle 2; doage increased to 375 mg/m2 on day 10 and 12
    Indication: Burkitt's Leukaemia

Cyclophosphamide
    Dosage: for 5 days in cycle 1
    Indication: Burkitt's Leukaemia

Methotrexate
    Dosage: on day 1 of cycle 2,4 and 6

Dexamethasone
    Dosage: on days 1-5 of cycle 3,5 and 7
    Indication: Burkitt's Leukaemia

Rituximab
    Dosage: day 8 on cycle 2; doage increased to 375 mg/m2 on day 10 and 12
    Indication: Burkitt's Lymphoma

Prednisone TAB
    Dosage: for 7 days in cycle 1
    Indication: Burkitt's Lymphoma

Prednisone TAB
    Dosage: for 7 days in cycle 1
    Indication: Burkitt's Leukaemia

Ifosfamide
    Dosage: on days 1-5 in cycle 2,4 and 6
    Indication: Burkitt's Leukaemia

Methotrexate
    Dosage: on day 1 of cycle 3,5 and 7
    Indication: Burkitt's Lymphoma

Vincristine
    Dosage: on day 1 of cycle 3,5 and 7
    Indication: Burkitt's Lymphoma

Dexamethasone
    Dosage: on days 1-5 of cycle 2,4 and 6

Other drugs received by patient: Unknown Medication; Leucovorin Calcium; Filgrastim



Possible Methotrexate side effects in male

Reported by a individual with unspecified qualification from Italy on 2012-06-18

Patient: male

Reactions: Epstein-Barr Virus Infection, Diarrhoea, Anaemia, Sepsis, Cytomegalovirus Infection, Neutropenia, Thrombocytopenia, Infection

Adverse event resulted in: death

Drug(s) suspected as cause:
Cyclophosphamide
    Indication: Burkitt's Lymphoma

Methotrexate
    Indication: Burkitt's Lymphoma

Vincristine Sulfate
    Indication: Burkitt's Lymphoma

Cytarabine
    Indication: Burkitt's Lymphoma

Cisplatin
    Indication: Burkitt's Lymphoma

Methylprednisolone
    Indication: Burkitt's Lymphoma

Etoposide
    Indication: Burkitt's Lymphoma

Mabthera
    Indication: Burkitt's Lymphoma

Doxorubicin Hydrochloride
    Indication: Burkitt's Lymphoma



Possible Methotrexate side effects in

Reported by a physician from United States on 2012-06-15

Patient:

Reactions: Hyperbilirubinaemia, Gastrointestinal Haemorrhage, Platelet Disorder, Transaminases Increased, Pericardial Effusion, Off Label Use, Hypophosphataemia, Subdural Haematoma, Urogenital Haemorrhage, Diarrhoea, Hypocalcaemia, Pleural Effusion, Infection

Drug(s) suspected as cause:
Cyclophosphamide
    Indication: Chronic Myeloid Leukaemia

Vincristine Sulfate
    Indication: Chronic Myeloid Leukaemia

Vincristine Sulfate
    Indication: Acute Lymphocytic Leukaemia

Dexamethasone
    Indication: Chromosome Analysis Abnormal

Methotrexate
    Indication: Chromosome Analysis Abnormal

Dasatinib
    Dosage: first 14 days of each of 8 cycles of alternating hypercvad
    Administration route: Oral
    Indication: Chronic Myeloid Leukaemia

Dasatinib
    Dosage: first 14 days of each of 8 cycles of alternating hypercvad
    Administration route: Oral
    Indication: Chromosome Analysis Abnormal

Dasatinib
    Dosage: first 14 days of each of 8 cycles of alternating hypercvad
    Administration route: Oral
    Indication: Acute Lymphocytic Leukaemia

Cyclophosphamide
    Indication: Acute Lymphocytic Leukaemia

Dexamethasone
    Indication: Acute Lymphocytic Leukaemia

Cytarabine
    Indication: Acute Lymphocytic Leukaemia

Methotrexate
    Indication: Chronic Myeloid Leukaemia

Doxorubicin HCL
    Indication: Chromosome Analysis Abnormal

Doxorubicin HCL
    Indication: Chronic Myeloid Leukaemia

Doxorubicin HCL
    Indication: Acute Lymphocytic Leukaemia

Cyclophosphamide
    Indication: Chromosome Analysis Abnormal

Cytarabine
    Indication: Chromosome Analysis Abnormal

Cytarabine
    Indication: Chronic Myeloid Leukaemia

Methotrexate
    Indication: Acute Lymphocytic Leukaemia

Vincristine Sulfate
    Indication: Chromosome Analysis Abnormal

Dexamethasone
    Indication: Chronic Myeloid Leukaemia



Possible Methotrexate side effects in male

Reported by a physician from Italy on 2012-06-14

Patient: male

Reactions: Epstein-Barr Virus Infection, Anaemia, Cytomegalovirus Infection, Neutropenia, Thrombocytopenia, Disease Progression, Infection

Drug(s) suspected as cause:
Carmustine
    Indication: Burkitt's Lymphoma

Carboplatin
    Indication: Burkitt's Lymphoma

Rituximab
    Indication: Burkitt's Lymphoma

Etoposide
    Indication: Burkitt's Lymphoma

Cytarabine
    Indication: Burkitt's Lymphoma

Vincristine
    Indication: Burkitt's Lymphoma

Melphalan Hydrochloride
    Indication: Burkitt's Lymphoma

Radiotherapy
    Indication: Burkitt's Lymphoma

Cyclophosphamide
    Indication: Burkitt's Lymphoma

Cisplatin
    Indication: Burkitt's Lymphoma

Doxorubicin HCL
    Indication: Burkitt's Lymphoma

Methotrexate
    Indication: Burkitt's Lymphoma

Ifosfamide
    Indication: Burkitt's Lymphoma

Granulocyte Colony Stimulating Factor
    Indication: Burkitt's Lymphoma

Methylprednisolone
    Indication: Burkitt's Lymphoma

Unknown Medication
    Dosage: antimicrobial prophylaxis
    Indication: Burkitt's Lymphoma

Other drugs received by patient: Unknown Medication



Possible Methotrexate side effects in

Reported by a physician from United States on 2012-06-12

Patient:

Reactions: Death, Burkitt's Lymphoma Recurrent, Neoplasm Malignant, Myelodysplastic Syndrome, Burkitt's Leukaemia, Infection

Adverse event resulted in: death

Drug(s) suspected as cause:
Doxorubicin HCL
    Indication: Burkitt's Lymphoma

Vincristine
    Indication: Burkitt's Lymphoma

Methotrexate
    Indication: Burkitt's Lymphoma

Monoclonal Antibodies
    Dosage: standard dose
    Indication: Burkitt's Lymphoma

Cytarabine
    Indication: Acute Lymphocytic Leukaemia

Monoclonal Antibodies
    Dosage: standard dose
    Indication: Acute Lymphocytic Leukaemia

Rituximab
    Dosage: days 1, 11 of hyper-cvad and days 1, 8 of mtx-cytarabine courses
    Indication: Acute Lymphocytic Leukaemia

Cyclophosphamide
    Indication: Acute Lymphocytic Leukaemia

Doxorubicin HCL
    Indication: Acute Lymphocytic Leukaemia

Cyclophosphamide
    Indication: Burkitt's Lymphoma

Cytarabine
    Indication: Burkitt's Lymphoma

Rituximab
    Dosage: days 1, 11 of hyper-cvad and days 1, 8 of mtx-cytarabine courses
    Indication: Burkitt's Lymphoma

Dexamethasone
    Indication: Acute Lymphocytic Leukaemia

Dexamethasone
    Indication: Burkitt's Lymphoma

Vincristine
    Indication: Acute Lymphocytic Leukaemia

Methotrexate
    Indication: Acute Lymphocytic Leukaemia

Other drugs received by patient: Unknown Medication



Possible Methotrexate side effects in 70 year old female

Reported by a health professional (non-physician/pharmacist) from Canada on 2012-06-12

Patient: 70 year old female

Reactions: Breast Lump Removal, Oral Surgery, Localised Infection, Swelling Face, Buccal Mucosal Roughening, Metastases To Liver, Mucosal Inflammation, Osteonecrosis of JAW, Neoplasm Malignant, JAW Disorder, Bone Disorder, Lymphadenectomy, Metastases To Bone, Infection

Drug(s) suspected as cause:
Pamidronate Disodium
    Dosage: drug name reported as pamidronate disodium for injection
    Indication: Product Used FOR Unknown Indication

Fluorouracil
    Indication: Product Used FOR Unknown Indication

Methotrexate
    Indication: Product Used FOR Unknown Indication

Gemcitabine
    Indication: Product Used FOR Unknown Indication

Cyclophosphamide
    Indication: Product Used FOR Unknown Indication

Xeloda
    Indication: Product Used FOR Unknown Indication

Epirubicin Hydrochloride
    Indication: Product Used FOR Unknown Indication

Taxotere
    Indication: Product Used FOR Unknown Indication



Possible Methotrexate side effects in male

Reported by a consumer/non-health professional from United States on 2012-06-12

Patient: male, weighing 119.8 kg (263.5 pounds)

Reactions: Intervertebral Disc Protrusion, Fistula, Gout, Diabetes Mellitus, Abasia, Convulsion, Cholelithiasis, Perineal Cyst, Decreased Immune Responsiveness, Diarrhoea, Heart Rate Increased, Intervertebral Disc Degeneration, Abnormal Loss of Weight, Oxygen Saturation Decreased, Infection

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Remicade
    Start date: 2010-01-01

Levemir
    Dosage: 52 units/ at night/subcutaneous
    Indication: Diabetes Mellitus

Colchicine
    Administration route: Oral
    Indication: Gout
    Start date: 2012-05-01

Remicade
    Indication: Crohn's Disease
    Start date: 2004-09-01
    End date: 2010-01-01

Novolog
    Dosage: 40 units/solution before meals
    Indication: Diabetes Mellitus
    Start date: 2011-01-01
    End date: 2011-01-01

Methotrexate
    Administration route: Oral
    Indication: Intervertebral Disc Protrusion
    Start date: 2011-01-01
    End date: 2011-01-01



Possible Methotrexate side effects in

Reported by a health professional (non-physician/pharmacist) from Croatia (Local Name: Hrvatska) on 2012-06-08

Patient:

Reactions: Infection

Adverse event resulted in: death

Drug(s) suspected as cause:
Etoposide
    Dosage: days 4, 5
    Indication: Burkitt's Leukaemia

Cytarabine
    Dosage: on days 4, 5
    Indication: Burkitt's Leukaemia

Methylprednisolone
    Indication: Prophylaxis

Mesna
    Indication: Burkitt's Leukaemia

Vincristine
    Dosage: on day 1
    Indication: Burkitt's Leukaemia

Ifosfamide
    Dosage: on days 1-5
    Indication: Burkitt's Lymphoma

Etoposide
    Dosage: days 4, 5
    Indication: Burkitt's Lymphoma

Dexamethasone
    Dosage: on days 1-5
    Indication: Burkitt's Leukaemia

Cytarabine
    Indication: Prophylaxis

Rituximab
    Indication: Burkitt's Leukaemia

Radiation Therapy NOS
    Dosage: 30-36 gy
    Indication: Burkitt's Leukaemia

Doxorubicin HCL
    Dosage: on days 4, 5
    Indication: Burkitt's Leukaemia

Doxorubicin HCL
    Dosage: on days 4, 5
    Indication: Burkitt's Lymphoma

Cyclophosphamide
    Dosage: on days 1-5
    Indication: Burkitt's Lymphoma

Vincristine
    Dosage: on day 1
    Indication: Burkitt's Lymphoma

Methotrexate
    Dosage: on day 1 with folinic acid rescue
    Indication: Burkitt's Lymphoma

Methotrexate
    Indication: Prophylaxis

Mesna
    Indication: Burkitt's Lymphoma

Rituximab
    Indication: Burkitt's Lymphoma

Cyclophosphamide
    Dosage: on days 1-5
    Indication: Burkitt's Leukaemia

Ifosfamide
    Dosage: on days 1-5
    Indication: Burkitt's Leukaemia

Prednisone
    Dosage: days 1-5
    Indication: Burkitt's Leukaemia

Prednisone
    Dosage: days 1-5
    Indication: Burkitt's Lymphoma

Leucovorin Calcium
    Indication: Burkitt's Leukaemia

Methotrexate
    Dosage: on day 1 with folinic acid rescue
    Indication: Burkitt's Leukaemia

Cytarabine
    Dosage: on days 4, 5
    Indication: Burkitt's Lymphoma

Dexamethasone
    Dosage: on days 1-5
    Indication: Burkitt's Lymphoma

Leucovorin Calcium
    Indication: Burkitt's Lymphoma

Radiation Therapy NOS
    Dosage: 30-36 gy
    Indication: Burkitt's Lymphoma

Other drugs received by patient: Neupogen; Blood Products; Acyclovir; Antibiotics



Possible Methotrexate side effects in

Reported by a health professional (non-physician/pharmacist) from Croatia (Local Name: Hrvatska) on 2012-06-08

Patient:

Reactions: Infection

Adverse event resulted in: death

Drug(s) suspected as cause:
Cyclophosphamide
    Dosage: on days 1-5
    Indication: Burkitt's Lymphoma

Vincristine
    Dosage: on day 1
    Indication: Burkitt's Leukaemia

Ifosfamide
    Dosage: on days 1-5
    Indication: Burkitt's Lymphoma

Cytarabine
    Dosage: on days 4, 5
    Indication: Burkitt's Lymphoma

Cytarabine
    Indication: Prophylaxis

Prednisone
    Dosage: days 1-5
    Indication: Burkitt's Lymphoma

Methotrexate
    Dosage: on day 1 with folinic acid rescue
    Indication: Burkitt's Leukaemia

Methotrexate
    Dosage: on day 1 with folinic acid rescue
    Indication: Burkitt's Lymphoma

Cytarabine
    Dosage: on days 4, 5
    Indication: Burkitt's Leukaemia

Mesna
    Dosage: on days 1-5
    Indication: Burkitt's Leukaemia

Etoposide
    Dosage: days 4, 5
    Indication: Burkitt's Lymphoma

Methylprednisolone
    Indication: Prophylaxis

Mesna
    Dosage: on days 1-5
    Indication: Burkitt's Lymphoma

Leucovorin Calcium
    Indication: Burkitt's Leukaemia

Radiation Therapy NOS
    Dosage: 30-36 gy
    Indication: Burkitt's Lymphoma

Cyclophosphamide
    Dosage: on days 1-5
    Indication: Burkitt's Leukaemia

Vincristine
    Dosage: on day 1
    Indication: Burkitt's Lymphoma

Radiation Therapy NOS
    Dosage: 30-36 gy
    Indication: Burkitt's Leukaemia

Doxorubicin HCL
    Dosage: on days 4, 5
    Indication: Burkitt's Leukaemia

Etoposide
    Dosage: days 4, 5
    Indication: Burkitt's Leukaemia

Prednisone
    Dosage: days 1-5
    Indication: Burkitt's Leukaemia

Leucovorin Calcium
    Indication: Burkitt's Lymphoma

Ifosfamide
    Dosage: on days 1-5
    Indication: Burkitt's Leukaemia

Dexamethasone
    Dosage: on days 1-5
    Indication: Burkitt's Lymphoma

Doxorubicin HCL
    Dosage: on days 4, 5
    Indication: Burkitt's Lymphoma

Dexamethasone
    Dosage: on days 1-5
    Indication: Burkitt's Leukaemia

Methotrexate
    Indication: Prophylaxis

Other drugs received by patient: Neupogen; Acyclovir; Antibiotics; Blood Products



Possible Methotrexate side effects in

Reported by a physician from United States on 2012-06-07

Patient:

Reactions: Infection

Adverse event resulted in: death

Drug(s) suspected as cause:
Vincristine
    Indication: Acute Lymphocytic Leukaemia

Cytarabine
    Indication: Acute Lymphocytic Leukaemia

Dasatinib
    Dosage: continuously for the next 7 cycles
    Administration route: Oral
    Indication: Acute Lymphocytic Leukaemia

Doxorubicin Hydrochloride
    Indication: Acute Lymphocytic Leukaemia

Dexamethasone
    Indication: Acute Lymphocytic Leukaemia

Rituximab
    Dosage: first 4 cycles
    Indication: Acute Lymphocytic Leukaemia

Cyclophosphamide
    Indication: Acute Lymphocytic Leukaemia

Methotrexate
    Indication: Acute Lymphocytic Leukaemia

Prednisone TAB
    Indication: Acute Lymphocytic Leukaemia

Dasatinib
    Administration route: Oral



Possible Methotrexate side effects in

Reported by a physician from United States on 2012-06-07

Patient:

Reactions: Off Label Use, Graft Versus Host Disease, Haemorrhage, Adverse Event, Organ Failure, Infection

Adverse event resulted in: death

Drug(s) suspected as cause:
Methotrexate
    Indication: Acute Lymphocytic Leukaemia

Cyclophosphamide
    Dosage: hyperfractionated
    Indication: Acute Lymphocytic Leukaemia

Tyrosine Kinase Inhibitor
    Indication: Acute Lymphocytic Leukaemia

Imatinib Mesylate
    Indication: Acute Lymphocytic Leukaemia

Dexamethasone
    Dosage: hyperfractionated
    Indication: Acute Lymphocytic Leukaemia

Vincristine

Cytarabine
    Indication: Acute Lymphocytic Leukaemia

Doxorubicin HCL
    Dosage: hyperfractionated
    Indication: Acute Lymphocytic Leukaemia

Nilotinib
    Indication: Acute Lymphocytic Leukaemia

Vincristine
    Dosage: hyperfractionated
    Indication: Acute Lymphocytic Leukaemia

Dasatinib
    Indication: Acute Lymphocytic Leukaemia

Asparaginase
    Indication: Acute Lymphocytic Leukaemia



Possible Methotrexate side effects in male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-05

Patient: male, weighing 102.6 kg (225.7 pounds)

Reactions: Cardio-Respiratory Arrest, Respiratory Failure, Anaemia, Troponin I Increased, Thrombocytopenia, Infection

Adverse event resulted in: death, life threatening event, hospitalization

Drug(s) suspected as cause:
Methotrexate
    Dosage: 1600 mg, cyclic
    End date: 2011-07-28

Adriamycin PFS
    Dosage: 101 mg, cyclic
    Indication: Mantle Cell Lymphoma
    Start date: 2011-07-05
    End date: 2011-07-05

Rituximab
    Dosage: 750 mg, cyclic
    Indication: Mantle Cell Lymphoma
    Start date: 2011-07-01
    End date: 2011-07-26

Methotrexate
    Dosage: 400 mg, cyclic
    Indication: Mantle Cell Lymphoma
    End date: 2011-07-27

Cytarabine
    Dosage: 6 g, cyclic
    Indication: Mantle Cell Lymphoma
    End date: 2011-07-30

Dexamethasone
    Dosage: 40 mg, cyclic
    Indication: Mantle Cell Lymphoma

Dexamethasone
    Dosage: 20 unk, unk
    Administration route: Oral
    End date: 2011-07-15

Vincristine
    Dosage: 2 mg, cyclic
    Indication: Mantle Cell Lymphoma
    Start date: 2011-07-05
    End date: 2011-07-12

Velcade
    Dosage: 2.6 mg, cyclic
    Indication: Mantle Cell Lymphoma
    Start date: 2011-07-01
    End date: 2011-07-26

Cyclophosphamide
    Dosage: 603 mg, cyclic
    Indication: Mantle Cell Lymphoma
    Start date: 2011-07-02
    End date: 2011-07-04

Other drugs received by patient: Filgrastim; Ferrous Sulfate TAB; Heparin; Senokot; Triamcinolone Acetonide; Compazine; Ciprofloxacin; Fluconazole; Omeprazole; Mesna; Prevident; Valtrex; Vitamin C / 00008001 /; Methylprednisolone; Periogard; Ultram; Vitamin D



 Page 1   Next >>

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017